Demographics (2)
- Age - Age of patient (phv00278052.v1.p1)
- Gender - Participant's gender as Male or Female (phv00278051.v1.p1)
Other (13)
- ANALYTE_Type - Molecular analyte (phv00278059.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00278046.v1.p1)
- FISH - Chromosomal alterations as identified by Fluorescence in situ Hybridization (FISH) (phv00278055.v1.p1)
- IgHV - Mutational status of the Immunoglobulin Heavy Chain Variable Region Genes (IgHV) (phv00278054.v1.p1)
- Primary Disease - Primary disease state of patient (phv00278053.v1.p1)
- SAMPID - De-identified Sample ID (phv00278056.v1.p1)
- SAMPID - Sample ID (phv00278048.v1.p1)
- Sample Type - Indicates the Tumor / Normal status of a sample (phv00278057.v1.p1)
- SAMPLE_USE - Use of samples. Seq_DNA_SNP_MAF_Sum: Samples were used to generate aggregate mutation annotation file (.maf); Seq_DNA_WholeExome: Whole exome sequencing; Seq_RNA: Whole transcriptome sequencing (phv00278049.v1.p1)
- SUBJID - Unique Participant Identifier (phv00278050.v1.p1)
- SUBJID - Subject ID (phv00278047.v1.p1)
- SUBJID - Subject ID (phv00278045.v1.p1)
- Tumor Type - Indicates primary or secondary tumor (phv00278058.v1.p1)